antiretroviral%20therapy%20for%20hiv-infected%20adults
ANTIRETROVIRAL THERAPY FOR HIV-INFECTED ADULTS
Antiretroviral therapy is recommended for all HIV-infected individuals regardless of CD4 count to decrease morbidity and mortality associated with HIV infection.
Goals of antiretroviral treatment are suppression of viral load for maximum possible duration, restore & preserve immunologic function, reduce HIV-related morbidity & mortality and prevent HIV transmission.
Urgent initiation of antiretroviral treatment is recommended in the following individuals: pregnant women, patients w/ HIV with coinfections (HBV, HCV, active tuberculosis), AIDS-defining illness, HIV-associated nephropathy, low CD4 counts, acute opportunistic infections and HIV HBV with evidence of chronic liver disease.

Antiretroviral Therapy for HIV-Infected Adults Drug Information

Drug Information

Indication: HIV-1 infection in combination w/ other antiretroviral agents in treatment-naive adults.

Indication: HIV-1 infection in antiretroviral treatment-experienced adult patients in combination w/ a boosted PI & ot...

Indication: HIV infection in antiretroviral treatment-experienced adult patients (in combination w/ ritonavir & other ...

Indication: In combination w/ other antiretroviral agents for HIV-1 infections in adult & paed patients ≥12 yr. Chr...

Indication: HIV infected adults & adolescents >12 yr in combination w/ other antiretroviral drugs.

Indication: In combination w/ other antiretroviral for treatment of HIV infected adult & childn.

Indication: HIV infection. 

Indication: HIV infection.

Indication: HIV infection.

Indication: Reduction of maternal-foetal transmission rate of HIV. Syr: In combination w/ other antiretroviral agents for ...

1  /  4
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Infectious Diseases - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pearl Toh, 22 Oct 2020
The combination therapy comprising carfilzomib, cyclophosphamide and dexamethasone (KCd) is effective, with a tolerable safety profile, in an Asian cohort with high-risk multiple myeloma (MM) — thus providing a more economical alternative as a potential upfront regimen in resource-limited settings, according to leading experts during a myeloma education webinar.
Roshini Claire Anthony, 13 Nov 2020

Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.

Pearl Toh, 6 days ago
Inhaled corticosteroid (ICS) should be the mainstay of long-term asthma management — such is the key message of the latest Singapore ACE* Clinical Guidance (ACG) for asthma, released in October 2020.
Elvira Manzano, 17 Nov 2020
Invasive fungal infections, particularly those caused by Candida species, are common in hospitalized, immunocompromised, or critically ill patients and are associated with considerable morbidity and mortality.